209
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Non-invasive magnetic resonance thermometry using thulium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (TmDOTA-)

, , , &
Pages 165-179 | Published online: 09 Jul 2009
 

Abstract

Non-invasive thermometry is pivotal to the future advances of regional hyperthermia as a cancer treatment modality. Current magnetic resonance (MR) thermometry methods suffer from poor thermal resolution due to relatively weak dependence of chemical shift of the 1 H water signal on temperature. This study evaluated the feasibility of using thulium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate (TmDOTA-) for MR thermometry. TmDOTA- is non-toxic and the gadolinium complex of DOTA4- is widely used as a MR contrast agent. The results demonstrate that the temperature dependence of the TmDOTA- proton shifts are about two orders of magnitudes higher than the water proton and, thus, provide excellent accuracy and resolution. In addition, TmDOTA - proton shifts are insensitive to the paramagnetic complex concentration, pH, Ca2+ or presence of plasma macromolecules and ions. Because hyperthermia is known to produce changes in tissue pH and other physiological parameters, these properties of TmDOTA- greatly simplify the procedures for using the lanthanide complex for MR thermometry. Application of TmDOTA- for measurement of temperature in a subcutaneously implanted human melanoma xenograft is demonstrated. Finally, the feasibility of imaging one of the 1H resonances of the lanthanide complex is demonstrated in phantom experiments. Overall, TmDOTA- appears to be a promising probe for MR thermometry in vivo.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.